Nerve Repair Market Size, Share, & COVID-19 Impact Analysis | Global | 2022-2028 | MedCore | Includes: Nerve Wraps, and 1 more

Overall, the global nerve repair market was valued at $104 million in 2021. This is expected to increase over the forecast period at a CAGR of 9.2% to reach $192 million by 2028.

The full report suite on the global market for nerve repair includes the nerve wrap and tube markets.

MARKET REPORT DATA TYPES INCLUDED:

• Unit Sales, Average Selling Prices, Market Size & Growth Trends

• Procedure Numbers

• COVID-19 Impact Analysis

• Market Drivers & Limiters

• Market Forecasts Until 2028, and Historical Data to 2018

• Recent Mergers & Acquisitions

• Company Profiles and Product Portfolios

• Leading Competitors

PROCEDURE NUMBERS

Approximately 70% of people with diabetes suffer from some form of nerve damage.The global nerve repair market is a fast-growing market. An increasing number of surgeons are adopting the products available on the market and the results seen are very promising.

GLOBAL NERVE REPAIR MARKET TRENDS

In recent years, the products on the market have been getting a lot better and are slowly establishing a new gold standard for nerve repair. However, there are still some limitations with the current products on the market. In the past, the main focus of a traumatic injury was the fixation of a fracture or wound closure, however, now nerve damage is also seen as a problem that needs to be fixed instead of a byproduct that can be lived with.

GLOBAL NERVE REPAIR MARKET SHARE INSIGHTS

Overall, within the global nerve repair market there are three dominant competitors: Axogen, Stryker, and Integra Lifesciences.

In 2021, the market leader in the global nerve repair market was Axogen. The company focuses on the science, development and commercialization of technologies for peripheral nerve regeneration and repair.

GLOBAL NERVE MARKET SEGMENTATION SUMMARY

• Nerve Wrap Market
• Nerve Tube Market
• Research Scope Summary
• Report Attribute
• Details

Regions:

• North America (Canada, United States)

• Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela)

• Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.)

• Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine)

• Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates)

• Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam)

• Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)

• Base Year: 2021
• Forecast Period: 2022-2028
• Historical Data: 2018-2021

• Quantitative Data: Market Size, Market Share, Market Growth Rates, Units Sold, Average Selling Prices

• Qualitative Data: COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios

• Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data.

Read more about iData's 9-Step Research Methodology.

WHY CHOOSE iDATA?

• Experts Only - iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.

• Global Coverage - iData's unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.

• Attention to Detail - It's our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.

• Pricing - When comparing like-with-like, iData's prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.